NCT05309668 2025-12-18
SPRINKLE
AstraZeneca
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT00913068 2021-10-04
TAP
Nova Scotia Health Authority
Phase NA Completed
NCT00632424 2016-03-10
Phase 1 Trial of Oral Ixabepilone
R-Pharm
Phase 1 Terminated
NCT00317642 2014-04-14
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
Sanofi
Phase 3 Completed